Chiesi Group’s new Biotech Center of Excellence brings the future of medicine to Parma, Italy | PR Newswire [Video]

• Chiesi Group is making a strategic investment of € 400 million to establish its new Biotech Center of Excellence in Parma
• The Center is designed to integrate the entire supply chain, enhancing innovation and production, while its seamless research-production integration will accelerate product development and autonomous production capacity
• Chiesi’s strategy aligns with EU priorities on innovation, security, and private R&D investment

, /PRNewswire/ — Chiesi Group, an international biopharmaceutical company focused on research, celebrated the operational launch of its Biotech Center of Excellence. This state-of-the-art facility is dedicated to developing and producing monoclonal antibodies, enzymes, and other proteins.

This facility is expected to be outstanding in Europe for its integrated approach, housing the entire supply chain under one roof. From the production of drug substances from mammalian cells to their transformation into drug products and final packaging, everything will be done in a single location. The new site’s seamless integration of research and industrial production …